Does ETOPOSIDE Cause Neoplasm recurrence? 156 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Neoplasm recurrence have been filed in association with ETOPOSIDE (Avopef). This represents 0.3% of all adverse event reports for ETOPOSIDE.
156
Reports of Neoplasm recurrence with ETOPOSIDE
0.3%
of all ETOPOSIDE reports
28
Deaths
30
Hospitalizations
How Dangerous Is Neoplasm recurrence From ETOPOSIDE?
Of the 156 reports, 28 (17.9%) resulted in death, 30 (19.2%) required hospitalization, and 31 (19.9%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETOPOSIDE. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does ETOPOSIDE Cause?
Off label use (6,495)
Febrile neutropenia (5,966)
Disease progression (3,776)
Drug ineffective (3,687)
Neutropenia (3,641)
Thrombocytopenia (3,085)
Product use in unapproved indication (2,774)
Anaemia (2,586)
Pyrexia (2,453)
Sepsis (2,211)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
PREDNISONE (144)
DEXAMETHASONE (135)
Which ETOPOSIDE Alternatives Have Lower Neoplasm recurrence Risk?
ETOPOSIDE vs ETORICOXIB
ETOPOSIDE vs ETRASIMOD ARGININE
ETOPOSIDE vs ETRAVIRINE
ETOPOSIDE vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL
ETOPOSIDE vs EVEROLIMUS